INtravitreal and Aqueous Dexamethasone Levels After DEXtenza

Clinical trial NCT04529512 · UNKNOWN

Trial details

NCT number: NCT04529512
Sponsor: Nathan Steinle
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Ocular Disease Requiring Surgery

Start date: 2021-03-01
Primary completion: 2021-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.